Byeong G. Song
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Carvedilol versus Propranolol in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study.
Journal: Liver cancer
Published: May 18, 2026
Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.
Journal: Alimentary pharmacology & therapeutics
Published: May 11, 2026
KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).
Journal: Clinical and molecular hepatology
Published: May 09, 2026
Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study.
Journal: Diabetes & metabolism
Published: May 06, 2026
Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study.
Journal: European radiology
Published: April 03, 2026
Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 12, 2026
E-cigarette switching, smoking cessation, and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide cohort study in South Korea.
Journal: Preventive medicine
Published: December 21, 2025
Physical Activity Improves Overall Survival in Patients with Hepatocellular Carcinoma.
Journal: Liver cancer
Published: December 15, 2025
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial.
Journal: Cancer immunology, immunotherapy : CII
Published: November 18, 2025
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis.
Journal: Annals of hepatology
Published: November 15, 2025
Safety and Efficacy of Combining Metastasis-Directed Stereotactic Ablative Radiation Therapy with Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors in Metastatic Hepatocellular Carcinoma.
Journal: Cancer research and treatment
Published: September 05, 2025
Last Updated: 09/26/2026